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ASCARIS SUUM: PARTIAL FRACTIONATION OF METABOLIC
ANTIGENS FROM IN VITRO CULTURED LARVAE.
Jorge Guerrero * and Paul H. Silverman **
Ascaris suum metabolic antigens were obtaineã from seconã and early 
third stage larvae cultureã in vitro in supplemented Eagle’s m lnim um essential 
medium. Metabolic antigens harvested after 12 and 16 days from  in vitro cul- 
tures were eluted through Bio-Gel A l.5.
Three main elution peaks were identified, dialysed, lyophilized and injected 
into mice w ith 4% sodium alginate. Peak II from elution of two preparations 
of metabolic antigens protected mice against a challenge infection of 10,000 
A. suum embryonateâ eggs.
INTRODU CTION
Ascaris suum  larval metabolic fluids 
nave been shown to be good protective 
antigens when injected into mice, prior 
to an infection (13, 14, 15). Because of the 
complexity of the medium in whicíi the 
larvae ihave to be grown (23) there might 
bs a diminution of the immune response 
due to the presence of competing non- 
protective immunogens.
It is well known th a t the simultaneous 
exposure of an  animal to several antigens 
decreases the immune response to some 
of the antigens in the mixture (1, 2, 11, 12). 
It is, therefore, desirable to separate a 
complex antigenic mixture into its com- 
ponents. One of the preferred methods with
the least biological damage to the antigens 
is fractionation on the basis of molecular 
size differences using filtration through a 
column of agarose gels. These are more 
rigid th an  many other gels and have low 
compressibility so th a t a good flow rate 
and reproducible separation migih t bs in- 
sured (18).
The present paper concerns attem pts to 
isolate the A. suum  metabolic larval inti- 
gens from the culture medium using ex- 
clusion chromatography.
MATERIALS AND METHODS
Animais. One hundred and ten albino 
Swiss mice averaging 22.2 ±  1.5 gm in 
weight were divided into 11 groups of 10 
animais each .
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Preparation of Ascaris suum. eggs. Eggs 
were embryonated following the method 
previously described by Guerrero and Sil- 
verman (14).
Preparation of antigens. Larval m eta­
bolic antigens of A. suum  were collected 
from in vitro cultures (23). Embryonated 
eggs were deshelled using the method of 
Haskins and Weinstein (16), hatched by the 
method of Jaskoski and Colucci (20), and 
cultured in sterile bottles in an  atmosphere 
of C02 a t 37°C for 12 and 16 days. Eagle’s 
minimum essential medium (MEM) plus 
10% antibiotic mixture (both from Grand 
Island Biological Co; 3175 Staley Road, 
Grand Island, N.Y. 14072) and 10% pig 
serum was used in the culture medium.
On day 12 and 16 the cultures were 
term inated and the number of dead and 
live larvae assessed and expressed as a 
percentage of the total. The total num ­
ber of larvae in culture in the batch th a t 
was m aintained in vitro for 12 days was 
36,000, of which 70% were in the early 
third stage, showing 35% viability (i.e. 
activily m oving). The larval batch th a t 
was cultured for 16 days had a total of 
34,000 larvae, 90% of which were in the 
early or m idthird stage according to the 
criteria of Douvres and Tromba (7); this 
culture showed a 32% viability.
Once the concentration was ascertained 
the larvae in the culture medium were 
sedimented a t 1600 g for 10 minutes in a 
refrigerated centrifuge. Immediately after 
centrifugation the supernate medium was 
applisd to the gel in the chromatography 
column.
Column chromatography. Bio-Gel A l.5, 
100-200 mesh, was obtained fully swollen 
in Tris EDTA buffer 0.001M with 0.02% 
sodium azide from Bio-Rad Laboratoires 
(Richmond, C alifórnia). I t  was handled 
as described by Hjertén (17). A Pharm acia 
chromatography column^ K2.5/45cms. was 
used after washing several times with 
deionized distilled and 70% ethanol.
After drying, a gel bed of 42 cm. in 
height was poured into the column utiliz- 
ing the device described by Flodin (9). 
This gel bed was subseque.ntly washed with 
500 ml of Tris HC1 0.1M at a 7.4pH to 
eliminate the sodium azide. The same buf­
fer was used as an  eluent. Ali the chro­
matography experiments were carried on 
a t 4°C. The approximate separation range 
of Bio-Gel A l.5 for proteins is between 
ten thousand and 1.5 million molecular 
weight (6). A fraction collector (Gil­
son Medicai Electronics, Middleton, Wis- 
consin) was used to collect fractians every 
3 ml of elution. Separation of the original 
compound was determined by scanning the 
fraction through a Beckman, DB Spectro- 
photometer a t 260 nm (for nucleid acids) 
and 280 nm (for proteinaceous materiais) 
(21). Samples to be separated were applied 
following the method described by Deter- 
m an (6), and were ali in a 10 ml volume.
The efficiency of the gel filtration 
technique and the baseline of elution was 
first assessed by eluting 10 ml of MEM 
plus 10% pig serum and 10% antibiotic 
mixture (supplement), then the 36,000 la r­
val equivalents (LE) of 12 days A. suum  
metabolic larval antigens in 10 ml MEM and 
supplement, and the 34.000 LE of 16 day 
A. suum  metabolic larval antigens in 10 ml 
MEM and supplement were eluted. Once 
the fractions th a t formed an elution peak 
were identified, they were pooled, dialyzed 
against demineralized H^O, lyophilized and 
stored a t 4°C until used. Three major 
peaks (I, II, and III) were identified at 
260 and 280 nm.
Estimãtion of protein concentration. 
The concentration of proteins in each 
antigenic fraction and in the medium used 
as control was estimated using the me­
thod by Lowry et al. (24) .
Aãjuvant and immunizing schedule. 
Four percent sodium alginate (Algivant 
Colab, Laboratoires, Inc., Chicago Heights, 
Illinois) was used in doses of 0.5 ml per 
anim al. Injections were adm inistred in tra- 
peritoneally on days 0 and 14.
Challenge inoculation procedures. Ali 
animais except the uninoculated control 
group, were challenged with dose of 10.000 
embryonated A. suum  eggs. The animal 
were inoculated per os on day 21 (i.e . 7 
days after the second immunizing in- 
jec tion).
Lung scoring technique. The mice were 
killed on day 28 (i.e. 7 days after inocul­
ation) by chloroforming, and the degree 
of infection was assessed by scoring visible
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petechiae in the lungs. This method was 
devised by Brown and Chen (5), and was 
modified by Lehnert (22). I t  employs an 
arbitrary scale according to the number 
and size of hemorrhages on the lungs, 
grading them  from 0 to 5. A lung score 
of zero represents completely normal lungs 
and a lung score of five represents com­
plete 'hepatization of both lungs or death 
of the infected animais as a consequence 
of the challenge infection.
Statistical analysis. The lung scores 
were analyzed as completely Randomized 
Design with Bayes’ least significant dif- 
ference at approximately 5% probality (8).
Experimental design. Mice in groups 
1 to 3 received two injections of adjuvant 
and 1800 LE of each A. suum  metabolic 
antigen fraction from larvae cultured in 
vitro for 12 days and eluted through Bio- 
Gel Al.5 Mice in group 1 were injected 
with fraction I, and each mouse received
0.742 mg of protein per injection; mice 
in group 2 were injected with fraction II, 
and each mouse received 1.061 mg per 
injection; group 3 received two injections 
of fraction III and protein concentration 
of each injection per mouse was 0.445 mg.
Mice in groups 4 to 6 received two in­
jections of adjuvant and 1700 LE of each 
A. suum  metabolic antigen fraction from 
larvae cultured for 16 days in vitro and 
eluted through Bio-Gel Al. 5. Mice in 
group 4 were injected with fraction I, and 
each animal received 0.870 mg of protein 
per injection; mice in group 5 were in ­
jected with fraction II, and each mouse 
received 1.485 mg of protein per injection; 
group 6 received two injections of fraction 
III and the protein concentration of each 
injection per mouse was 0.615 mg.
Mice in groups 7, 8, and 9 Controls were 
inoculated with the products of elution of 
the medium and supplements through a 
Bio-Gel A l.5 column. Mice in group 7 
were injected with fraction I  and each 
mouse received 0.933 mg protein per in ­
jection; mice in group 8 were injected with 
fraction II, and each mouse received 0.976 
mg of protein per injection; group 9 was 
injected with fraction III, and each mouse 
got 0.403 mg of protein per injection.
Mice in group 10 were inoculated twice 
with 8,000 embryonated A. suum  eggs 21 
and 7 days before challenge and were con- 
sidered infection immunity control. Mice
in group 11 were injected twice with saline 
and were kept unínoculated as a normal 
background control.
RESULTS
The Bio-Gel A l.5 fractionation patterns 
of medium plus supplement, and of the 
larval metabolic antigens in a complex 
medium are presented in Figures 1 and 2. 
Three m ajor fractions are identified as 
indicated by their peak OD values a t 260 
and 280 nm and they were present in the 
complex medium, and metabolic antigens.
The concentration of proteins in each 
eluted fraction after concentration and 
reconstitution to 10 ml of volume is pre­
sented in Table I. The results indicate 
th a t most of the protein is eluted in fract­
ion II.
The results of the studies of immuno- 
ge.nieity of the fractionated A. suum  larval 
metabolic antigens are presented as mean 
lung scores in Table II. Fraction II from 
elution of A. suum, metabolic antigens from 
larvae cultured for 12 days in vitro con- 
ferred the best protection of ali experi­
m ental groups th a t were immunized with 
injections of antigen.
Fibrosis of the liver was absent in ani­
mais from groups 1, 2, 3, 4, 5, 6, 7, 8, 9, 
and 11, and present in 4 animais from 
group 10.
DISCUSSION
The results obtained in this experiment 
show th a t fraction II from the elution of 
A. suum  metabolic larval antfgens through 
Bio-Gel A l.5. is biologically active and 
induces a good degree of immunity. There 
seems to be no marked difference in bio- 
logical activity between fraction II from 
metabolites of larvae cultured in vitro for 
12 or 16 days. This results confirm those 
found by Guerrero (13) using Sephadex 
G-200 as the gel for exclusion chromato- 
graphy.
There is no significant difference (at 
the 5% levei) between the mean lung 
scores of groups 2 vs. 5. There is a signi­
ficant difference (at the 5% levei) between 
the mean lung scores of groups 2 vs. 1, 3, 
4, 6, 7, 8, 9, 10 and 11. In this particular 
experiment the best protection against the 
migration of A. suum  larvae was conferred 
by previous infections.
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TABLE I
Total Concentration of Protein in 10 ml of Each Concentrated Antigens Fraction After 
Elution Through a Bio-Gel A l.5 Column.
Complex medium and Complex medium and 
12 day metabolic 16 day metabolic
larval antigens larval antigens Complex medium
Fraction I . 
Fraction II 
Fraction III
14.85 mg 
21.22 mg 
8.91 mg
17.40 mg 
29.70 mg 
12.30 mg
18.67 mg 
19.52 mg 
8.06 mg
TABLE II
Lung Lesion Scores on Day 7 Following Inoculation of Mice with Embryonated Ascaris suum  Eggs
Grcup Mean
N<? Treatm ent Lung
Scores *
1 Fraction I (Bio-Gel A1.5m) of 3,600 LE of metabolic antigens from 12 day old larvae and adjuvant 2.5
2 Fraction II (Bio-Gel A1.5m) of 3,600 LE of metabolic antigens from 12 day old larvae and adjuvant 1.4
3 Fraction III (Bio-Gel A1.5m) of 3,600 LE of metabolic antigens from 12 day old larvae and adjuvant 3.0
4 Fraction I (Bio-Gel A1.5m) of 3,400 LE of metabolic antigens from 16 day old larvae and adjuvant 2.4
5 Fraction II (Bio-Gel A1.5m) of 3,400 LE of metabolic antigens from 16 day old larvae and adjuvant 1.5
6 Fraction III (Bio-Gel A1.5m) of 3,400 LE of metabolic antigens from 16 day old larvae and adjuvant 2.1
7 Fraction I (Bio-Gel A1.5m) of MEM plus supplement and adjuvant (control) ..................................... 3.1
8 Fraction II (Bio-Gel A1.5m) of MEM plus supplement and adjuvant (control) ..................................... 3.4
9 Fraction III (Bio-Gel A1.5m) of MEM plus supplement and adjuvant (control) ..................................... 2.7
10 Infection immunity control ........................................................................................................................................... 0.3
11 Uninoculated (background) normal control ............................................................................................................  0.3
* Bayes leas t s ig n if ic a n t d ifference .51
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Bio-Gel A l.5 'has been found to be sa- 
tisfactory for the separation of biologically 
active macromolecules obtained from the 
metabolites of A. suum  larvae cultured in 
vitro. The exclusion chromatography pro- 
file using this type of gel were completely 
reproducible, and the results obtained 
suggest th a t the molecular weights of the 
metabolic products correspond to materiais 
with a molecular weight higher th an  10,000 
(minimum fractionation range from Bio- 
Gel Al.5) (3). According to Boyd (4)
antigens must have more th an  a certain 
minimal degree of complexity and mole­
cular weight; this minimal molecular 
weight in synthetic polypeptide antigens 
is as low as between 4 and 5 thousand 
(29). Hogarth-Scott (19) found th a t the 
allergic activity resided in the second 
psak in helm inth allergens after filtra t­
ion of Ascaris body fluid through Sephadex 
G-75, and th a t peak was found to be form- 
ed by molecules of more than  50,000 in 
MW. Oliver-Gonzales and Gadea (26) 
found 3 m ain peaks after filtration of the 
coelomic fluid of A. suum  adults, through 
a Sephadex G-200 column.
Oliver-Gonzales et al. (27) utilized the 
first psak of this elution in the diagnosis 
of v sceral larvae migrans. Utilizing an 
indirect hem agglutination test, they were 
able to relate positive serologic results 
with previous contact of the patients not 
only with the homologous antigen, but 
with the antigens from migrating larvae. 
They claim to have found the same type 
of antigens in th ird  and fourth stage A. 
suum larvae. Unfortunately, these authors 
did not describe the way they collected 
these larval antigens or if they were used 
in protection trials. Ozerol and Silverman 
(28), found th a t the biologically active 
fractions of metabolites from third and 
fourth stage Haemonchus contortus larvae 
is the one formed by the heavy molecules 
th a t are eluted in the first peak after 
filtration through Sephadex G-200. They 
were able to separate further this active 
fraction into 3 more of different molecular 
weights but they did not test them  to find 
the one responsible for the induction of 
resistance to the infection.
The doses of antigen given to the ex­
perimental animais were between 0.403 mg 
to 1.485 mg of protein per mouse. Accord­
ing to Mitchison (25) these should be 
considered actively immunizing doses in
mice. Using BSA injected in mice, he 
found th a t low doses (1-10 jug) induced 
low zone paralysis, and th a t higher doses 
of the order of 100 /u g to 1 mg immunize, 
while still higher doses (5-50mg) paralyse.
The culture system used in this éxpe- 
rim ent is suitable for the m aintenance and 
development of A. suum  larvae. Eagle’s 
Minimum Essential Medium supplemented 
with 10% pig serum and 10% antibiotic 
mixture provided a good nutrient medium 
in which larvae grew and developed to a 
point where functional metabolic antigens 
were released. The viability of larvae at 
the end of the in vitro culture period, ex­
presses the percentage of active larvae in 
the culture on the last day of incubation, 
but does not represent the number of de- 
veloping larvae in the system during the 
period of culture. Because the culture 
medium is not sufficient to make larvae 
reach adulthood, when larvae reach the 
third stage most of them die due to lack 
of proper nutrients or perhaps stimulus. 
Levine and Silverman (23)) found th a t a 
protein was especially necessary for the 
development of the late second and early 
third stage of A. suum  larvae; Douvres and 
Tromba (7) also found th a t the highest 
yields of advanced stages of A. suum  were 
obtained when the medium was supple­
mented with swine kidney cells, calf or 
swine serum.
A disadvantage of the culture system 
utilized in this experiment is th a t the me­
dium was not completely defined, and th a t 
the larvae needed the presence of 10% 
pig serum to survive and develop. Until 
in vitro cultures and metabolic antigen 
production is carried on in a completely 
defined medium, free of macromolecular 
supplements, the characterization of A. 
suum  larval functional antigens will be 
a problem. An alternative way to solve 
this problem could be the elimination of 
these supplements by immunological or 
chemical methods.
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SUMARIO
Os antígenos metabólicos de Ascaris suum foram obtidos de larvas de se­
gundo e de terceiro estágio (precoce) cultivadas in vitro em meio mínimo es­
sencial de Eeagle com suplemento proteico. Os antígenos metabólicos coletados 
depois de 12 a 16 dias das culturas in vitro foram eluidos em Bio-Gel Al 5.
Três picos de eluição foram identificados, dializados, liofilizados e injetados 
em camundongos, com alginato de sódio a 4%. O pico II da eluição de duas 
preparações dos antígenos metabólicos protegeram os camundongos da infecção 
com 10.000 ovos infectivos de A. suum.
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